CBDBY Statistics
Total Valuation
CBDBY has a market cap or net worth of 369.45 million. The enterprise value is 1.68 billion.
| Market Cap | 369.45M |
| Enterprise Value | 1.68B |
Important Dates
The next estimated earnings date is Thursday, February 19, 2026.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +25.46% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 33.11% |
| Owned by Institutions (%) | 45.60% |
| Float | 169.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 1.50 |
| P/FCF Ratio | 2.48 |
| P/OCF Ratio | 1.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.56, with an EV/FCF ratio of 11.30.
| EV / Earnings | -6.61 |
| EV / Sales | 0.46 |
| EV / EBITDA | 7.56 |
| EV / EBIT | 28.20 |
| EV / FCF | 11.30 |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 3.07.
| Current Ratio | 0.70 |
| Quick Ratio | 0.36 |
| Debt / Equity | 3.07 |
| Debt / EBITDA | 7.48 |
| Debt / FCF | 10.47 |
| Interest Coverage | 0.22 |
Financial Efficiency
Return on equity (ROE) is -25.47% and return on invested capital (ROIC) is 1.29%.
| Return on Equity (ROE) | -25.47% |
| Return on Assets (ROA) | 0.82% |
| Return on Invested Capital (ROIC) | 1.29% |
| Return on Capital Employed (ROCE) | 2.20% |
| Revenue Per Employee | 32,786 |
| Profits Per Employee | -2,313 |
| Employee Count | 110,000 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 7.12 |
Taxes
| Income Tax | -110.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +82.50% in the last 52 weeks. The beta is 1.41, so CBDBY's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +82.50% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.57 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 13,668 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CBDBY had revenue of 3.61 billion and -254.44 million in losses. Loss per share was -0.52.
| Revenue | 3.61B |
| Gross Profit | 989.04M |
| Operating Income | 46.53M |
| Pretax Income | -271.89M |
| Net Income | -254.44M |
| EBITDA | 121.96M |
| EBIT | 46.53M |
| Loss Per Share | -0.52 |
Balance Sheet
The company has 256.69 million in cash and 1.56 billion in debt, giving a net cash position of -1.30 billion.
| Cash & Cash Equivalents | 256.69M |
| Total Debt | 1.56B |
| Net Cash | -1.30B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 507.19M |
| Book Value Per Share | 1.03 |
| Working Capital | -381.47M |
Cash Flow
In the last 12 months, operating cash flow was 262.51 million and capital expenditures -113.71 million, giving a free cash flow of 148.80 million.
| Operating Cash Flow | 262.51M |
| Capital Expenditures | -113.71M |
| Free Cash Flow | 148.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 27.42%, with operating and profit margins of 1.29% and -7.06%.
| Gross Margin | 27.42% |
| Operating Margin | 1.29% |
| Pretax Margin | -7.54% |
| Profit Margin | -7.06% |
| EBITDA Margin | 3.38% |
| EBIT Margin | 1.29% |
| FCF Margin | 4.13% |
Dividends & Yields
CBDBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.46% |
| Shareholder Yield | -25.46% |
| Earnings Yield | -68.87% |
| FCF Yield | 40.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 18, 2010. It was a forward split with a ratio of 2.
| Last Split Date | Oct 18, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
CBDBY has an Altman Z-Score of 1.05 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 5 |